Medications

Potential new treatment for COVID-19 identified

Researchers have identified a potential new treatment that suppresses the replication of SARS-CoV-2, the coronavirus that causes COVID-19. In order to multiply, all viruses, including coronaviruses, infect cells and reprogram ...

Oncology & Cancer

Researchers create comprehensive database of head and neck cancers

In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins ...

Medical research

Making bones is less difficult than was previously thought

The way in which bone formation occurs needs to be redefined. This was revealed by Radboud university medical center researchers and their colleagues in a publication in Nature Communications. It turns out that bone formation ...

Oncology & Cancer

Scientists identify new target for wide array of cancers

Many types of human cancers exhibit changes in kinase and phosphatase balances. Drugs that inhibit kinase activity have shown success in the clinic as cancer therapeutics, but the phosphatases still remain a largely underexploited ...

Genetics

Discovery shows promise for treating Huntington's disease

Huntington's disease is a progressive and aggressively debilitating brain disorder that causes uncontrolled movements, psychological problems, and loss of cognition. It is caused by a mutation in the gene that encodes the ...

Oncology & Cancer

Mystery about the cancer drug nelarabine solved after decades

Acute lymphoblastic leukemia (ALL) is the most common kind of cancer in children. T-ALL, a subtype that resembles T-lymphocytes, can be treated successfully with the drug nelarabine. The drug has not been successful, however, ...

page 2 from 11